Home

Download

Statistics

Examples

Help

Contact

Gene: ENSG00000151882

Summary for CCL28

Gene summary

Gene information	Ensembl ID	ENSG00000151882
	Gene symbol	CCL28
	Gene name	C-C motif chemokine ligand 28
	HGNC	17700
	Entrez ID	56477
	Gene type	protein_coding
	Synonyms	CCL28\|SCYA28\|MEC\|CCK1
	UniProtAcc	Q9NRJ3

Drugs associated with this gene(DrugBank).

Gene ID

Gene Symbol

Drug ID

Drug Name

Drug Type

Cancer therapeutic drugs associated with this gene(NCI).

Gene ID

Gene Name

Drug ID

Drug Name

Drug Type

Cancer

Top

Structure and expression level for CCL28

AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.
∗For more information on exon skipping events please check the ExonskipDB database.
∗For more information on exon skipping events please check the CAeditome database.

Landscape of gene expressions across multiple cancer types.

Differentially expressed gene analysis between tumor male and tumor female samples.

Coding Name	Base Mean	log2FoldChange	lfcSE	Stat	P value	P.adjust Value	Cancer Type
CCL28	1.75e+03	-1.75e+00	5.37e-01	-3.25e+00	1.15e-03	1.26e-02	BRCA

Differentially expressed gene analysis between tumor male and normal male samples.

Coding Name	Base Mean	log2FoldChange	lfcSE	Stat	P value	P.adjust Value	Cancer Type
CCL28	2.23e+03	-1.11e+00	3.62e-01	-3.08e+00	2.08e-03	5.35e-03	STAD
CCL28	1.79e+03	2.36e+00	3.60e-01	6.55e+00	5.78e-11	3.90e-10	KIRP

Differentially expressed gene analysis between tumor female and normal female samples.

Coding Name	Base Mean	log2FoldChange	lfcSE	Stat	P value	P.adjust Value	Cancer Type
CCL28	6.84e+02	1.08e+00	2.45e-01	4.43e+00	9.42e-06	2.46e-05	LUAD
CCL28	2.48e+03	-2.43e+00	1.80e-01	-1.35e+01	1.54e-41	1.17e-40	BRCA
CCL28	1.23e+03	-2.29e+00	5.50e-01	-4.16e+00	3.14e-05	1.76e-04	READ

Top

Sex-biased somatic mutation for CCL28

∗For more information on exon skipping events please check the ExonskipDB database.

Gene ID

Cancer Type

Hugo Symbol

Male

Female

pval

ci.up

ci.low

adjPval

Top

DNA methylation with beta values for CCL28

Landscape of DNA methylation across multiple cancer types.

Differentially expressed CpG sites between male tumor and female tumor patients.

Cancer Type

CpG Site

Position

CpG Island

Position to Gene

ave1

ave2

wilcoxon.w

wilcoxon.p

padj

dBeta

Differentially expressed CpG sites between male tumor and male normal patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
KIRC	cg14076417	chr5:43412499	CGI:chr5:43396795-43397262	promoter	7.54e-01	8.74e-01	-3.36e+00	7.76e-04	1.24e-03	-1.20e-01
LUAD	cg26237003	chr5:43413107	CGI:chr5:43396795-43397262	promoter	7.28e-01	8.54e-01	-2.01e+00	4.43e-02	4.53e-02	-1.27e-01
HNSC	cg14076417	chr5:43412499	CGI:chr5:43396795-43397262	promoter	5.40e-01	7.10e-01	-3.52e+00	4.33e-04	8.92e-04	-1.70e-01
HNSC	cg26237003	chr5:43413107	CGI:chr5:43396795-43397262	promoter	6.87e-01	8.19e-01	-2.79e+00	5.26e-03	7.42e-03	-1.32e-01
BLCA	cg23863670	chr5:43411827	CGI:chr5:43396795-43397262	promoter,gene body	7.01e-01	8.30e-01	-2.68e+00	7.35e-03	1.11e-02	-1.30e-01
KIRP	cg26237003	chr5:43413107	CGI:chr5:43396795-43397262	promoter	8.95e-01	7.88e-01	6.05e+00	1.49e-09	5.40e-08	1.07e-01
CHOL	cg03326188	chr5:43412363	CGI:chr5:43396795-43397262	UTR,promoter,exon,gene body	4.75e-01	6.89e-01	-2.14e+00	3.25e-02	3.87e-02	-2.15e-01

Differentially expressed CpG sites between female tumor and female normal patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
BRCA	cg26237003	chr5:43413107	CGI:chr5:43396795-43397262	promoter	7.18e-01	8.27e-01	-3.55e+00	3.86e-04	5.36e-04	-1.09e-01
HNSC	cg03326188	chr5:43412363	CGI:chr5:43396795-43397262	UTR,promoter,exon,gene body	4.59e-01	3.13e-01	2.76e+00	5.78e-03	1.42e-02	1.46e-01
COAD	cg03077492	chr5:43412993	CGI:chr5:43396795-43397262	promoter	6.64e-01	5.06e-01	2.30e+00	2.16e-02	2.75e-02	1.59e-01
COAD	cg26237003	chr5:43413107	CGI:chr5:43396795-43397262	promoter	5.25e-01	3.74e-01	2.33e+00	1.98e-02	2.59e-02	1.50e-01

Top

Exon skipping events with PSI in TCGA for CCL28

∗Please access ExonSkipDB for exon skipping annotation.

Landscape of exon skipping events across multiple cancer types.

Differentially expressed exon skipping events between male tumor and female tumor patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Differentially expressed exon skipping events between male tumor and male normal patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Differentially expressed exon skipping events between female tumor and female normal patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Top

RNA A-to-I editing events in TCGA for CCL28

∗Please access CAeditome for RNA editing annotation.

Landscape of RNA editing events across multiple cancer types.

Differentially expressed RNA editing events between male tumor and female tumor patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
KIRC	CCL28-001	chr5_43377370_-	1.87e-01	2.21e-01	-2.34e+00	1.93e-02	4.45e-02	-3.35e-02
KIRC	CCL28-001	chr5_43377380_-	2.88e-01	2.52e-01	2.54e+00	1.12e-02	4.20e-02	3.57e-02
KIRC	CCL28-001	chr5_43377392_-	1.94e-01	2.23e-01	-2.30e+00	2.15e-02	4.55e-02	-2.91e-02
KIRC	CCL28-001	chr5_43377440_-	3.39e-01	3.14e-01	2.38e+00	1.72e-02	4.41e-02	2.46e-02
KIRC	CCL28-001	chr5_43378852_-	2.13e-01	1.90e-01	2.17e+00	3.00e-02	4.67e-02	2.24e-02
KIRC	CCL28-003	chr5_43381556_-	1.31e-01	1.73e-01	-1.97e+00	4.84e-02	4.97e-02	-4.21e-02
LUAD	CCL28-001	chr5_43378839_-	1.75e-01	2.28e-01	-2.32e+00	2.01e-02	3.80e-02	-5.31e-02
THCA	CCL28-001	chr5_43378839_-	2.03e-01	1.55e-01	2.24e+00	2.50e-02	4.91e-02	4.76e-02
THCA	CCL28-001	chr5_43380707_-	1.88e-01	1.42e-01	2.15e+00	3.19e-02	4.91e-02	4.65e-02
THCA	CCL28-003	chr5_43381559_-	1.88e-01	1.63e-01	2.80e+00	5.18e-03	4.77e-02	2.52e-02
THCA	CCL28-003	chr5_43381597_-	3.21e-01	2.92e-01	2.40e+00	1.64e-02	4.91e-02	2.88e-02
THCA	CCL28-003	chr5_43381606_-	3.14e-01	2.82e-01	2.35e+00	1.89e-02	4.91e-02	3.26e-02
HNSC	CCL28-001	chr5_43378861_-	3.21e-01	2.42e-01	2.07e+00	3.84e-02	4.59e-02	7.92e-02
LUSC	CCL28-001	chr5_43380806_-	1.79e-01	2.46e-01	-2.69e+00	7.11e-03	4.91e-02	-6.72e-02
SKCM	CCL28-001	chr5_43377335_-	1.88e-01	1.23e-01	1.97e+00	4.92e-02	4.95e-02	6.52e-02
SKCM	CCL28-001	chr5_43378849_-	4.15e-01	3.79e-01	1.98e+00	4.80e-02	4.91e-02	3.67e-02
SKCM	CCL28-001	chr5_43380584_-	1.28e-01	1.84e-01	-2.76e+00	5.70e-03	4.90e-02	-5.58e-02
SKCM	CCL28-003	chr5_43381511_-	2.21e-01	2.47e-01	-1.99e+00	4.65e-02	4.90e-02	-2.62e-02
STAD	CCL28-001	chr5_43380621_-	1.81e-01	2.16e-01	-2.20e+00	2.78e-02	4.96e-02	-3.45e-02
LIHC	CCL28-001	chr5_43377409_-	2.28e-01	1.47e-01	2.13e+00	3.29e-02	4.63e-02	8.09e-02
LIHC	CCL28-003	chr5_43381462_-	2.52e-01	3.04e-01	-2.42e+00	1.57e-02	4.30e-02	-5.18e-02
LIHC	CCL28-003	chr5_43381559_-	2.60e-01	1.91e-01	2.02e+00	4.29e-02	4.82e-02	6.89e-02
KIRP	CCL28-001	chr5_43378849_-	4.13e-01	3.33e-01	3.59e+00	3.37e-04	2.82e-02	7.93e-02
KIRP	CCL28-003	chr5_43381639_-	3.71e-01	3.36e-01	2.14e+00	3.20e-02	4.72e-02	3.47e-02
SARC	CCL28-001	chr5_43377286_-	2.06e-01	2.96e-01	-2.25e+00	2.48e-02	4.85e-02	-9.03e-02
PAAD	CCL28-001	chr5_43377392_-	1.52e-01	2.39e-01	-2.79e+00	5.26e-03	4.66e-02	-8.65e-02
PAAD	CCL28-001	chr5_43377440_-	2.92e-01	3.96e-01	-3.76e+00	1.71e-04	4.66e-02	-1.03e-01
PAAD	CCL28-003	chr5_43381497_-	1.31e-01	1.81e-01	-3.13e+00	1.73e-03	4.66e-02	-5.03e-02
READ	CCL28-003	chr5_43381462_-	2.01e-01	1.58e-01	2.41e+00	1.59e-02	4.85e-02	4.28e-02
ESCA	CCL28-001	chr5_43377380_-	2.52e-01	3.13e-01	-2.12e+00	3.38e-02	4.99e-02	-6.09e-02
UVM	CCL28-001	chr5_43377286_-	1.73e-01	2.35e-01	-2.24e+00	2.50e-02	4.93e-02	-6.21e-02

Differentially expressed RNA editing events between male tumor and male normal patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
KIRC	CCL28-003	chr5_43381498_-	2.13e-01	1.68e-01	3.16e+00	1.57e-03	5.07e-03	4.53e-02
KIRC	CCL28-003	chr5_43381606_-	3.33e-01	2.74e-01	2.88e+00	3.94e-03	9.67e-03	5.87e-02
THCA	CCL28-001	chr5_43378861_-	2.41e-01	1.69e-01	2.58e+00	9.92e-03	1.89e-02	7.22e-02
THCA	CCL28-001	chr5_43378878_-	2.35e-01	1.64e-01	2.88e+00	4.01e-03	1.08e-02	7.12e-02
HNSC	CCL28-001	chr5_43377286_-	2.57e-01	1.70e-01	3.11e+00	1.86e-03	3.69e-03	8.75e-02
HNSC	CCL28-001	chr5_43377288_-	2.78e-01	1.20e-01	2.84e+00	4.48e-03	7.42e-03	1.58e-01
HNSC	CCL28-001	chr5_43377383_-	2.77e-01	1.38e-01	2.19e+00	2.83e-02	3.19e-02	1.39e-01
HNSC	CCL28-001	chr5_43378852_-	2.80e-01	1.60e-01	2.87e+00	4.14e-03	6.95e-03	1.20e-01
HNSC	CCL28-001	chr5_43378861_-	3.21e-01	1.97e-01	3.19e+00	1.42e-03	3.00e-03	1.24e-01
HNSC	CCL28-001	chr5_43378874_-	2.37e-01	1.52e-01	2.72e+00	6.43e-03	9.87e-03	8.55e-02
HNSC	CCL28-001	chr5_43380635_-	2.67e-01	1.74e-01	2.62e+00	8.75e-03	1.27e-02	9.30e-02
HNSC	CCL28-001	chr5_43380716_-	2.47e-01	1.88e-01	2.67e+00	7.48e-03	1.11e-02	5.87e-02
HNSC	CCL28-001	chr5_43380806_-	1.84e-01	1.25e-01	2.16e+00	3.07e-02	3.40e-02	5.89e-02
LUSC	CCL28-001	chr5_43380598_-	1.82e-01	3.04e-01	-2.99e+00	2.80e-03	8.80e-03	-1.22e-01
LUSC	CCL28-003	chr5_43381462_-	2.13e-01	2.72e-01	-2.55e+00	1.08e-02	2.03e-02	-5.92e-02
LUSC	CCL28-003	chr5_43381511_-	2.46e-01	3.87e-01	-3.01e+00	2.61e-03	8.42e-03	-1.40e-01
COAD	CCL28-001	chr5_43378874_-	2.38e-01	1.68e-01	2.51e+00	1.20e-02	1.94e-02	7.06e-02
COAD	CCL28-001	chr5_43378878_-	2.17e-01	1.43e-01	3.35e+00	8.15e-04	3.78e-03	7.39e-02
COAD	CCL28-001	chr5_43380715_-	2.46e-01	1.79e-01	2.05e+00	4.08e-02	4.33e-02	6.69e-02
COAD	CCL28-001	chr5_43380719_-	3.36e-01	2.66e-01	2.72e+00	6.43e-03	1.34e-02	6.98e-02
COAD	CCL28-001	chr5_43380720_-	2.43e-01	1.82e-01	2.89e+00	3.91e-03	9.61e-03	6.08e-02
STAD	CCL28-001	chr5_43380583_-	2.26e-01	1.65e-01	2.05e+00	4.00e-02	4.51e-02	6.13e-02
STAD	CCL28-001	chr5_43380716_-	2.96e-01	2.06e-01	2.71e+00	6.64e-03	1.96e-02	9.00e-02
KIRP	CCL28-001	chr5_43377440_-	3.11e-01	4.55e-01	-2.65e+00	8.07e-03	2.00e-02	-1.43e-01
KIRP	CCL28-001	chr5_43380719_-	2.53e-01	3.62e-01	-2.67e+00	7.61e-03	1.95e-02	-1.08e-01
ESCA	CCL28-001	chr5_43380719_-	3.97e-01	2.81e-01	2.09e+00	3.69e-02	4.19e-02	1.16e-01

Differentially expressed RNA editing events between female tumor and female normal patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
BRCA	CCL28-001	chr5_43377286_-	2.51e-01	2.04e-01	4.98e+00	6.35e-07	2.47e-06	4.78e-02
BRCA	CCL28-001	chr5_43377287_-	1.74e-01	1.24e-01	3.63e+00	2.80e-04	6.31e-04	4.96e-02
BRCA	CCL28-001	chr5_43377288_-	2.04e-01	1.52e-01	5.18e+00	2.21e-07	9.31e-07	5.20e-02
BRCA	CCL28-001	chr5_43377308_-	1.92e-01	1.27e-01	6.61e+00	3.91e-11	2.98e-10	6.49e-02
BRCA	CCL28-001	chr5_43377344_-	1.67e-01	1.26e-01	3.31e+00	9.37e-04	1.84e-03	4.11e-02
BRCA	CCL28-001	chr5_43377370_-	1.92e-01	1.32e-01	4.88e+00	1.06e-06	3.99e-06	6.01e-02
BRCA	CCL28-001	chr5_43377380_-	2.76e-01	1.98e-01	6.93e+00	4.07e-12	3.54e-11	7.83e-02
BRCA	CCL28-001	chr5_43377383_-	2.41e-01	1.47e-01	8.35e+00	6.88e-17	1.15e-15	9.42e-02
BRCA	CCL28-001	chr5_43377392_-	2.34e-01	1.74e-01	5.22e+00	1.82e-07	7.83e-07	5.90e-02
BRCA	CCL28-001	chr5_43377409_-	1.74e-01	1.24e-01	2.39e+00	1.67e-02	2.13e-02	5.02e-02
BRCA	CCL28-001	chr5_43377440_-	3.27e-01	2.67e-01	4.96e+00	6.96e-07	2.69e-06	5.99e-02
BRCA	CCL28-001	chr5_43377448_-	1.66e-01	1.22e-01	2.56e+00	1.05e-02	1.46e-02	4.36e-02
BRCA	CCL28-001	chr5_43377473_-	2.36e-01	1.44e-01	7.99e+00	1.37e-15	1.96e-14	9.19e-02
BRCA	CCL28-001	chr5_43377478_-	2.50e-01	1.82e-01	5.61e+00	1.97e-08	1.00e-07	6.72e-02
BRCA	CCL28-001	chr5_43377486_-	1.81e-01	1.17e-01	2.10e+00	3.59e-02	3.87e-02	6.36e-02
BRCA	CCL28-001	chr5_43378086_-	1.95e-01	1.20e-01	2.35e+00	1.88e-02	2.33e-02	7.56e-02
BRCA	CCL28-001	chr5_43378098_-	4.06e-01	2.35e-01	7.47e+00	7.93e-14	8.89e-13	1.71e-01
BRCA	CCL28-001	chr5_43378099_-	3.20e-01	1.51e-01	6.03e+00	1.59e-09	9.45e-09	1.69e-01
BRCA	CCL28-001	chr5_43378151_-	2.75e-01	1.65e-01	4.16e+00	3.24e-05	8.99e-05	1.10e-01
BRCA	CCL28-001	chr5_43378171_-	4.40e-01	2.70e-01	7.55e+00	4.19e-14	4.91e-13	1.70e-01
BRCA	CCL28-001	chr5_43378229_-	3.08e-01	2.18e-01	5.89e+00	3.85e-09	2.18e-08	9.06e-02
BRCA	CCL28-001	chr5_43378239_-	2.13e-01	1.75e-01	3.19e+00	1.41e-03	2.62e-03	3.77e-02
BRCA	CCL28-001	chr5_43378256_-	2.79e-01	1.97e-01	6.31e+00	2.72e-10	1.83e-09	8.19e-02
BRCA	CCL28-001	chr5_43378264_-	1.94e-01	1.16e-01	3.02e+00	2.55e-03	4.39e-03	7.74e-02
BRCA	CCL28-001	chr5_43378345_-	3.89e-01	2.54e-01	7.96e+00	1.70e-15	2.42e-14	1.36e-01
BRCA	CCL28-001	chr5_43378849_-	3.84e-01	3.32e-01	3.34e+00	8.37e-04	1.67e-03	5.20e-02
BRCA	CCL28-001	chr5_43378852_-	2.34e-01	1.66e-01	6.07e+00	1.29e-09	7.81e-09	6.89e-02
BRCA	CCL28-001	chr5_43378861_-	2.84e-01	2.50e-01	2.04e+00	4.11e-02	4.31e-02	3.40e-02
BRCA	CCL28-001	chr5_43378874_-	2.51e-01	1.92e-01	5.46e+00	4.76e-08	2.26e-07	5.90e-02
BRCA	CCL28-001	chr5_43378878_-	2.36e-01	1.70e-01	6.01e+00	1.80e-09	1.06e-08	6.53e-02
BRCA	CCL28-001	chr5_43380583_-	1.95e-01	1.19e-01	3.33e+00	8.80e-04	1.75e-03	7.58e-02
BRCA	CCL28-001	chr5_43380598_-	1.83e-01	1.31e-01	4.92e+00	8.83e-07	3.36e-06	5.13e-02
BRCA	CCL28-001	chr5_43380635_-	2.48e-01	1.33e-01	9.82e+00	9.30e-23	3.49e-21	1.15e-01
BRCA	CCL28-001	chr5_43380715_-	2.52e-01	1.50e-01	6.65e+00	2.96e-11	2.29e-10	1.02e-01
BRCA	CCL28-001	chr5_43380716_-	2.68e-01	1.47e-01	1.10e+01	4.14e-28	3.58e-26	1.21e-01
BRCA	CCL28-001	chr5_43380719_-	3.67e-01	2.51e-01	8.33e+00	8.20e-17	1.35e-15	1.16e-01
BRCA	CCL28-001	chr5_43380720_-	2.71e-01	1.44e-01	9.38e+00	6.37e-21	1.76e-19	1.28e-01
BRCA	CCL28-001	chr5_43380806_-	1.97e-01	1.36e-01	4.20e+00	2.63e-05	7.46e-05	6.14e-02
BRCA	CCL28-003	chr5_43381462_-	2.27e-01	1.40e-01	1.00e+01	1.47e-23	6.10e-22	8.65e-02
BRCA	CCL28-003	chr5_43381497_-	1.76e-01	1.37e-01	3.98e+00	6.97e-05	1.80e-04	3.86e-02
BRCA	CCL28-003	chr5_43381498_-	2.25e-01	1.43e-01	7.18e+00	7.22e-13	7.03e-12	8.10e-02
BRCA	CCL28-003	chr5_43381511_-	2.67e-01	1.93e-01	7.48e+00	7.44e-14	8.41e-13	7.44e-02
BRCA	CCL28-003	chr5_43381559_-	2.06e-01	1.28e-01	7.74e+00	9.81e-15	1.24e-13	7.82e-02
BRCA	CCL28-003	chr5_43381597_-	3.23e-01	2.24e-01	8.62e+00	6.63e-18	1.25e-16	9.91e-02
BRCA	CCL28-003	chr5_43381606_-	3.21e-01	2.16e-01	9.66e+00	4.51e-22	1.54e-20	1.05e-01
KIRC	CCL28-003	chr5_43381511_-	2.77e-01	1.91e-01	2.31e+00	2.07e-02	3.34e-02	8.61e-02
THCA	CCL28-001	chr5_43377286_-	2.59e-01	2.09e-01	3.03e+00	2.46e-03	6.49e-03	4.94e-02
THCA	CCL28-001	chr5_43377409_-	1.76e-01	1.43e-01	2.07e+00	3.84e-02	4.22e-02	3.32e-02
THCA	CCL28-001	chr5_43377440_-	3.09e-01	2.67e-01	2.65e+00	7.97e-03	1.47e-02	4.12e-02
THCA	CCL28-001	chr5_43377473_-	2.24e-01	1.91e-01	2.34e+00	1.90e-02	2.61e-02	3.34e-02
THCA	CCL28-001	chr5_43378268_-	2.60e-01	1.37e-01	3.37e+00	7.54e-04	2.78e-03	1.23e-01
THCA	CCL28-001	chr5_43378345_-	3.88e-01	3.13e-01	2.32e+00	2.03e-02	2.72e-02	7.49e-02
THCA	CCL28-001	chr5_43380583_-	1.80e-01	1.27e-01	2.21e+00	2.68e-02	3.32e-02	5.25e-02
THCA	CCL28-001	chr5_43380715_-	2.41e-01	1.72e-01	3.18e+00	1.49e-03	4.56e-03	6.83e-02
THCA	CCL28-001	chr5_43380716_-	2.46e-01	1.62e-01	4.49e+00	7.03e-06	8.71e-05	8.39e-02
THCA	CCL28-001	chr5_43380719_-	3.14e-01	2.41e-01	3.78e+00	1.60e-04	8.79e-04	7.29e-02
THCA	CCL28-001	chr5_43380720_-	2.22e-01	1.70e-01	2.98e+00	2.86e-03	7.21e-03	5.17e-02
THCA	CCL28-001	chr5_43380806_-	1.91e-01	1.40e-01	3.41e+00	6.54e-04	2.52e-03	5.06e-02
THCA	CCL28-003	chr5_43381497_-	1.53e-01	1.19e-01	2.34e+00	1.91e-02	2.62e-02	3.37e-02
THCA	CCL28-003	chr5_43381498_-	2.02e-01	1.51e-01	3.38e+00	7.23e-04	2.71e-03	5.11e-02
HNSC	CCL28-001	chr5_43377440_-	3.03e-01	2.27e-01	2.08e+00	3.73e-02	4.09e-02	7.54e-02
COAD	CCL28-001	chr5_43377288_-	2.21e-01	1.60e-01	2.12e+00	3.43e-02	4.01e-02	6.07e-02
COAD	CCL28-001	chr5_43377380_-	3.33e-01	2.14e-01	2.00e+00	4.54e-02	4.70e-02	1.19e-01
COAD	CCL28-001	chr5_43377392_-	2.74e-01	1.91e-01	2.36e+00	1.84e-02	2.82e-02	8.35e-02
COAD	CCL28-001	chr5_43377409_-	1.93e-01	1.24e-01	2.89e+00	3.81e-03	1.20e-02	6.95e-02
COAD	CCL28-001	chr5_43377478_-	2.93e-01	2.02e-01	2.06e+00	3.93e-02	4.26e-02	9.07e-02
STAD	CCL28-003	chr5_43381559_-	2.42e-01	1.64e-01	2.09e+00	3.68e-02	4.45e-02	7.80e-02
READ	CCL28-003	chr5_43381597_-	3.45e-01	2.33e-01	2.31e+00	2.09e-02	4.19e-02	1.12e-01

Protein coding RNA editing(s).

Editing Position

Variant Type

Gene Symbol

Transcript ID

NTchange

AAchange

Top

Sex-biased TF-Gene network for CCL28

TFs related to CCL28.
∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.

Cancer Type	TF	Target Gene	Male Edge Score	Male Edge Threshold	Female Edge Score	Female Edge Threshold	Type
CHOL	ZNF418	CCL28	3.03e+00	2.12e-03	4.35e+00	9.91e-01	Female-biased
CHOL	ZNF716	CCL28	3.63e+00	1.34e-02	4.48e+00	9.81e-01	Female-biased
CHOL	ZNF879	CCL28	2.80e+00	4.10e-03	3.94e+00	9.82e-01	Female-biased
PAAD	BARX1	CCL28	5.08e+00	9.88e-01	4.22e+00	8.79e-03	Male-biased
PAAD	BPTF	CCL28	4.46e+00	9.92e-01	3.23e+00	1.27e-03	Male-biased
PAAD	CDX2	CCL28	4.77e+00	9.92e-01	3.71e+00	3.25e-03	Male-biased
PAAD	EVX2	CCL28	4.79e+00	9.92e-01	3.76e+00	3.73e-03	Male-biased
PAAD	FEZF1	CCL28	4.13e+00	9.85e-01	3.08e+00	3.16e-03	Male-biased
PAAD	HSFY1	CCL28	5.50e+00	9.83e-01	4.76e+00	1.56e-02	Male-biased
PAAD	HSFY2	CCL28	5.43e+00	9.89e-01	4.57e+00	8.91e-03	Male-biased
PAAD	MSX1	CCL28	5.15e+00	9.92e-01	4.18e+00	5.07e-03	Male-biased
PAAD	MSX2	CCL28	5.10e+00	9.91e-01	4.17e+00	6.27e-03	Male-biased
PAAD	NKX6-1	CCL28	4.49e+00	9.90e-01	3.43e+00	3.17e-03	Male-biased
PAAD	POU2F2	CCL28	4.92e+00	9.93e-01	3.88e+00	3.49e-03	Male-biased
PAAD	POU5F1	CCL28	4.92e+00	9.93e-01	3.89e+00	3.78e-03	Male-biased
PAAD	TBX6	CCL28	4.55e+00	9.84e-01	3.70e+00	9.48e-03	Male-biased
PAAD	YY1	CCL28	4.72e+00	9.87e-01	3.85e+00	8.38e-03	Male-biased
PAAD	ZFP82	CCL28	4.61e+00	9.92e-01	3.50e+00	2.50e-03	Male-biased
PAAD	ZNF33B	CCL28	4.97e+00	9.95e-01	3.74e+00	1.35e-03	Male-biased
PAAD	ZNF433	CCL28	5.58e+00	9.82e-01	4.84e+00	1.64e-02	Male-biased
PAAD	ZNF442	CCL28	4.36e+00	9.82e-01	3.52e+00	9.72e-03	Male-biased
PAAD	ZNF716	CCL28	4.67e+00	9.92e-01	3.57e+00	2.62e-03	Male-biased
PAAD	ZNF730	CCL28	4.27e+00	9.82e-01	3.40e+00	8.36e-03	Male-biased
PCPG	NKX6-1	CCL28	3.20e+00	6.84e-03	4.08e+00	9.81e-01	Female-biased
PCPG	ZFP82	CCL28	3.26e+00	6.94e-03	4.14e+00	9.82e-01	Female-biased
PCPG	ZNF33B	CCL28	3.70e+00	9.33e-03	4.52e+00	9.85e-01	Female-biased
SKCM	ZNF418	CCL28	3.93e+00	6.82e-03	5.04e+00	9.87e-01	Female-biased
THYM	CDX2	CCL28	4.27e+00	8.53e-03	5.00e+00	9.88e-01	Female-biased
THYM	EVX2	CCL28	4.29e+00	9.19e-03	5.00e+00	9.87e-01	Female-biased
THYM	HSFY2	CCL28	4.91e+00	1.53e-02	5.50e+00	9.83e-01	Female-biased
THYM	MSX1	CCL28	4.76e+00	9.57e-03	5.47e+00	9.89e-01	Female-biased
THYM	MSX2	CCL28	4.76e+00	1.20e-02	5.41e+00	9.86e-01	Female-biased
THYM	NKX6-1	CCL28	4.31e+00	6.55e-03	5.11e+00	9.90e-01	Female-biased
THYM	POU2F2	CCL28	4.39e+00	9.93e-03	5.08e+00	9.87e-01	Female-biased
THYM	POU5F1	CCL28	4.47e+00	1.31e-02	5.10e+00	9.84e-01	Female-biased
THYM	ZFP82	CCL28	4.12e+00	5.73e-03	4.95e+00	9.90e-01	Female-biased
THYM	ZNF33B	CCL28	4.25e+00	3.92e-03	5.17e+00	9.93e-01	Female-biased
THYM	ZNF418	CCL28	4.27e+00	1.38e-03	5.46e+00	9.97e-01	Female-biased
THYM	ZNF716	CCL28	3.98e+00	3.49e-03	4.93e+00	9.92e-01	Female-biased
THYM	ZNF879	CCL28	3.91e+00	3.26e-03	4.88e+00	9.92e-01	Female-biased

CCL28 related gene.
∗Only the gene encode TF might with this result.
∗For more information please check Sex-biased TF-Coding gene network.

Top

Sex-biased RBP-ES network for CCL28

RBPs related to ES in CCL28.
∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.

Cancer Type

RBP

Target ES

Male Edge Score

Male Edge Threshold

Female Edge Score

Female Edge Threshold

Type

CCL28 related ES.
∗Only the gene encode RBP might with this result.
∗For more information please check Sex-biased RBP-ES network in cancer.

Top

Sex-biased CeRNA regulation of gene

Sex-biased CeRNA regulation of gene.

Gene ID

ceRNA(lncRNA-miRNA-mRNA)

Group

Cancer Type

Top

Sex-biased eQTL regulation of gene

Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

eQTL

Description

Male-specific eQTL regulation.

SNP ID	SNP Info	Position to Gene	Effect Score	FDR	Cancer Type	Biased Type
rs11742761	chr5:44301065:A:G	-	0.147615261010131	0.0430786141384477	READ	Female-baised eQTL
rs17316984	chr5:44315272:C:T	-	0.147615261010131	0.0430786141384477	READ	Female-baised eQTL
rs17234191	chr5:44347482:G:A	-	0.147615261010131	0.0430786141384477	READ	Female-baised eQTL
rs11743802	chr5:44351052:T:C	-	0.147615261010131	0.0430786141384477	READ	Female-baised eQTL
rs10512849	chr5:44384121:C:T	-	0.147615261010131	0.0430786141384477	READ	Female-baised eQTL
rs72750760	chr5:52688575:C:T	-	0.139373661324363	0.000135565948509336	LIHC	Female-baised eQTL
rs140773865	chr5:52643388:A:G	-	0.128260064280127	0.000350980450974262	LIHC	Female-baised eQTL
rs2648732	chr5:52776330:A:G	-	-0.124198236546492	0.000908843547828471	LIHC	Female-baised eQTL
rs79743638	chr5:52814738:A:G	-	0.123967035698453	0.000950613658643421	LIHC	Female-baised eQTL
rs3096173	chr5:52780456:A:G	-	-0.117010481621538	0.00230130988872328	LIHC	Female-baised eQTL
rs76255385	chr5:52815327:G:A	-	0.117010481621538	0.00230130988872328	LIHC	Female-baised eQTL
rs16880238	chr5:52786729:A:C	-	0.111085146980148	0.00456054044481931	LIHC	Female-baised eQTL
rs1363958	chr5:52775763:T:C	-	-0.105583237060079	0.00861970002431557	LIHC	Female-baised eQTL
rs2648733	chr5:52775826:A:G	-	-0.105583237060079	0.00861970002431557	LIHC	Female-baised eQTL
rs72752550	chr5:52725159:G:A	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752556	chr5:52727951:G:A	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752560	chr5:52729807:C:T	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752561	chr5:52731100:G:A	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752562	chr5:52732635:C:T	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs56926375	chr5:52733211:G:T	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs55673164	chr5:52736089:C:T	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752564	chr5:52736654:A:G	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752565	chr5:52737196:C:T	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs72752567	chr5:52738202:G:T	-	0.103953605761181	0.00863147985167186	LIHC	Female-baised eQTL
rs2548504	chr5:52775155:A:G	-	-0.105538597531968	0.00875565526989584	LIHC	Female-baised eQTL
rs2548503	chr5:52775205:T:C	-	-0.105538597531968	0.00875565526989584	LIHC	Female-baised eQTL
rs1363961	chr5:52775365:G:A	-	-0.105538597531968	0.00875565526989584	LIHC	Female-baised eQTL
rs1363960	chr5:52775390:G:A	-	-0.105538597531968	0.00875565526989584	LIHC	Female-baised eQTL
rs1363959	chr5:52775537:C:A	-	-0.105538597531968	0.00875565526989584	LIHC	Female-baised eQTL
rs72752532	chr5:52705921:A:G	-	0.103955110667318	0.00875565526989584	LIHC	Female-baised eQTL
rs61561406	chr5:52711757:A:G	-	0.103955110667318	0.00875565526989584	LIHC	Female-baised eQTL
rs58717249	chr5:52717716:G:C	-	0.103955110667318	0.00875565526989584	LIHC	Female-baised eQTL
rs184643180	chr5:52719768:C:T	-	0.103955110667318	0.00875565526989584	LIHC	Female-baised eQTL
rs140681849	chr5:52721177:C:T	-	0.103898025320993	0.00878594268660163	LIHC	Female-baised eQTL
rs111276746	chr5:52723169:A:T	-	0.103898025320993	0.00878594268660163	LIHC	Female-baised eQTL
rs1833884	chr5:52774720:G:A	-	-0.0954334170038335	0.0199129856560898	LIHC	Female-baised eQTL
rs1833883	chr5:52774727:T:C	-	-0.0954334170038335	0.0199129856560898	LIHC	Female-baised eQTL
rs2548506	chr5:52775081:G:A	-	-0.0875946180810064	0.0418257908519705	LIHC	Female-baised eQTL
rs2548505	chr5:52775096:A:G	-	-0.0875457144698745	0.042217476298172	LIHC	Female-baised eQTL
rs840390	chr5:34018518:G:A	-	0.117704671229826	0.00276544308273112	BLCA	Female-baised eQTL
rs253190	chr5:33994759:G:A	-	0.118335618919284	0.005656168078036	BLCA	Female-baised eQTL
rs183670	chr5:33992156:G:A	-	0.120640147194162	0.00593327465558692	BLCA	Female-baised eQTL
rs171681	chr5:33992349:T:C	-	0.120640147194162	0.00593327465558692	BLCA	Female-baised eQTL
rs253197	chr5:34010407:A:G	-	0.107501672961281	0.00855953644767437	BLCA	Female-baised eQTL
rs253199	chr5:34011568:G:A	-	0.107501672961281	0.00855953644767437	BLCA	Female-baised eQTL
rs253201	chr5:34013155:G:C	-	0.107501672961281	0.00855953644767437	BLCA	Female-baised eQTL
rs34677	chr5:33998663:C:A	-	0.0992562727516002	0.0232504643042119	BLCA	Female-baised eQTL
rs253193	chr5:34009916:C:T	-	0.0869160350262399	0.0307626768478443	BLCA	Female-baised eQTL
rs253194	chr5:34009949:A:G	-	0.0869160350262399	0.0307626768478443	BLCA	Female-baised eQTL
rs253195	chr5:34010201:T:C	-	0.0869160350262399	0.0307626768478443	BLCA	Female-baised eQTL
rs253196	chr5:34010211:G:A	-	0.0869160350262399	0.0307626768478443	BLCA	Female-baised eQTL
rs253198	chr5:34010534:T:C	-	0.0869160350262399	0.0307626768478443	BLCA	Female-baised eQTL
rs190418	chr5:34011251:G:T	-	0.0869160350262399	0.0307626768478443	BLCA	Female-baised eQTL
rs12520359	chr5:33930369:T:A	-	0.0854123664631207	0.017429530045676	LUAD	Female-baised eQTL
rs13177154	chr5:35667805:C:A	-	0.0325664293559674	0.0482064939728021	LUAD	Female-baised eQTL
rs17393674	chr5:37075819:A:T	-	0.1514533251926	0.00556820982905452	COAD	Female-baised eQTL

Female-specific eQTL regulation.

SNP ID	SNP Info	Position to Gene	Effect Score	FDR	Cancer Type	Biased Type
rs62360370	chr5:37814387:G:A	-	0.0995584592842703	0.00860782388078635	BLCA	Male-baised eQTL
rs150738565	chr5:42933305:G:A	-	0.0777716682081475	0.0104567568076511	BLCA	Male-baised eQTL
rs34426657	chr5:42935009:C:T	-	0.0777716682081475	0.0104567568076511	BLCA	Male-baised eQTL
rs79956724	chr5:42936078:C:A	-	0.0777716682081475	0.0104567568076511	BLCA	Male-baised eQTL
rs62360373	chr5:37820639:G:A	-	0.0933148473538275	0.0142660823825799	BLCA	Male-baised eQTL
rs62360371	chr5:37816932:C:T	-	0.0931206435061177	0.0147075652871509	BLCA	Male-baised eQTL
rs2603624	chr5:42911303:T:G	-	0.0551690715704992	0.0159829372171188	BLCA	Male-baised eQTL
rs16903732	chr5:37811999:G:A	-	0.091473678006858	0.0169347092894264	BLCA	Male-baised eQTL
rs62360369	chr5:37812047:G:C	-	0.091473678006858	0.0169347092894264	BLCA	Male-baised eQTL
rs11747340	chr5:37840346:G:A	-	0.098522121167402	0.0194014966323052	BLCA	Male-baised eQTL
rs62360376	chr5:37854586:A:T	-	0.098522121167402	0.0194014966323052	BLCA	Male-baised eQTL
rs75220215	chr5:37860836:G:T	-	0.0982612297113974	0.0200792792561004	BLCA	Male-baised eQTL
rs62360378	chr5:37860899:G:C	-	0.0982612297113974	0.0200792792561004	BLCA	Male-baised eQTL
rs2253157	chr5:42906470:A:C	-	0.0548407009570263	0.0227433150852177	BLCA	Male-baised eQTL
rs2603622	chr5:42912329:A:G	-	0.0550353402875539	0.0244276182930175	BLCA	Male-baised eQTL
rs421514	chr5:42872367:T:G	-	0.0561059142330659	0.0278973855432502	BLCA	Male-baised eQTL
rs2548364	chr5:42918380:T:C	-	0.0575621987699991	0.0279521761112175	BLCA	Male-baised eQTL
rs378235	chr5:42867900:T:A	-	0.0556885711391431	0.0302459283943785	BLCA	Male-baised eQTL
rs388214	chr5:42872369:G:A	-	0.0556885711391431	0.0302459283943785	BLCA	Male-baised eQTL
rs315253	chr5:42874399:A:G	-	0.0556885711391431	0.0302459283943785	BLCA	Male-baised eQTL
rs309932	chr5:42875352:C:T	-	0.0556885711391431	0.0302459283943785	BLCA	Male-baised eQTL
rs114353553	chr5:42859705:A:T	-	0.0557122428201223	0.0307263442270741	BLCA	Male-baised eQTL
rs7701142	chr5:42860108:T:C	-	0.0557122428201223	0.0307263442270741	BLCA	Male-baised eQTL
rs315261	chr5:42887992:A:G	-	0.105180482912611	0.0316378454965365	BLCA	Male-baised eQTL
rs9885101	chr5:42913209:C:A	-	0.053209712793204	0.0317522178393608	BLCA	Male-baised eQTL
rs78899997	chr5:37833581:G:A	-	0.0932878058957399	0.0329141733678173	BLCA	Male-baised eQTL
rs315246	chr5:42884125:A:G	-	0.0554812635372393	0.0355854002533155	BLCA	Male-baised eQTL
rs56000387	chr5:37831431:T:C	-	0.0916594681539936	0.0361708293525875	BLCA	Male-baised eQTL
rs17386472	chr5:37832696:C:T	-	0.0916594681539936	0.0361708293525875	BLCA	Male-baised eQTL
rs13156119	chr5:42911361:A:C	-	0.0520612386268079	0.0398748284751468	BLCA	Male-baised eQTL
rs10044301	chr5:42908236:C:A	-	0.0520074595335098	0.0399233852020329	BLCA	Male-baised eQTL
rs4513706	chr5:42909188:G:C	-	0.0517519174172076	0.0415596943593046	BLCA	Male-baised eQTL
rs12659760	chr5:42909923:C:T	-	0.0517519174172076	0.0415596943593046	BLCA	Male-baised eQTL
rs12655096	chr5:42907283:T:C	-	0.0546311181906933	0.0441609768767915	BLCA	Male-baised eQTL
rs75236196	chr5:40488557:T:C	-	0.0965812825930301	0.000220106989565323	LUAD	Male-baised eQTL
rs77091262	chr5:40494051:G:A	-	0.0965812825930301	0.000220106989565323	LUAD	Male-baised eQTL
rs78870278	chr5:40498079:C:T	-	0.0976843625310736	0.00022084930768166	LUAD	Male-baised eQTL
rs149137776	chr5:40498229:G:A	-	0.0976843625310736	0.00022084930768166	LUAD	Male-baised eQTL
rs113700968	chr5:40549520:G:A	-	0.089817349629985	0.000609286017005282	LUAD	Male-baised eQTL
rs10512738	chr5:40428699:A:G	-	0.0794924940662348	0.0196173557826521	LUAD	Male-baised eQTL
rs73750647	chr5:38251076:T:C	-	0.0878357933568888	0.0382874094602916	LUAD	Male-baised eQTL
rs73750649	chr5:38252643:A:C	-	0.0878357933568888	0.0382874094602916	LUAD	Male-baised eQTL
rs73750645	chr5:38248397:A:T	-	0.0847341439369988	0.0470376506509053	LUAD	Male-baised eQTL
rs73750646	chr5:38248982:G:C	-	0.0847341439369988	0.0470376506509053	LUAD	Male-baised eQTL

Opposite sex-biased eQTL regulation.

SNP ID

SNP Info

Position to Gene

Male Effect

Male FDR

Female Effect

Female FDR

Sex-biased Gene in Cancer

Cancer Type

Top

Sex-biased eQTM regulation of gene

Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table).

eQTM	Description
	Gene ID: ENSG00000151882
	CpG Site: cg03326188
	Position to Gene: gene,exon,promoter,UTR
	Male Effect: -0.412868107714997
	Female Effect: -
	Gene ID: ENSG00000151882
	CpG Site: cg03326188
	Position to Gene: gene,exon,promoter,UTR
	Male Effect: -0.0834311502207436
	Female Effect: -

Male-specific eQTM regulation.

CpG Site	CpG Postion	Position to Gene	Effect Score	FDR	Cor.r	Cor.Pvalue	Cancer Type
cg03326188	chr5:43412363	gene,exon,promoter,UTR	-0.412868107714997	3.49559115404865e-15	-0.5475191237348821	7.6740145595780485e-19	LUAD
cg03326188	chr5:43412363	gene,exon,promoter,UTR	-0.0834311502207436	5.48309621201451e-05	-0.31398675312599816	3.413249730589733e-07	LIHC

Female-specific eQTM regulation.

CpG Site

CpG Postion

Position to Gene

Effect Score

FDR

Cor.r

Cor.Pvalue

Cancer Type

Opposite sex-biased eQTM regulation.

CpG Site

CpG Postion

CpG Island

Position to Gene

Male Effect

Male FDR

Female Effect

Female FDR

Male Cor

Male P-value

Female Cor

Female P-value

Sex-biased Coding Gene

Cancer Type

Top

Sex-biased sQTL regulation of gene

Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

sQTL

Description

Male-specific sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Effect Score

FDR

Cancer Type

Biased Type

Female-specific sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Effect Score

FDR

Cancer Type

Biased Type

Opposite sex-biased sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Male Effect

Male FDR

Female Effect

Female FDR

Cancer Type

Top

Sex-biased sQTM regulation of gene

Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

sQTM

Description

Male-specific sQTM regulation.

EX ID

Skipped Exon

CPG Site

CPG Position

Position to EX Events

Effect Score

FDR

Cor.r

Cor.Pvalue

ORF_anno

Cancer Type

Female-specific sQTM regulation.

EX ID

Skipped Exon

CPG Site

CPG Position

Position to EX Events

Effect Score

FDR

Cor.r

Cor.Pvalue

ORF_anno

Cancer Type

Opposite sex-biased sQTM regulation.

EX ID

EX Info

Skipped Exon

CPG Site

CPG Position

CPG Island

Position to EX Events

Male Effect

Male FDR

Female Effect

Female FDR

Male Correlation

Male P-value

Female Correlation

Female P-value

ORF_anno

Cancer Type

Top

Related disease information of CCL28

Diseases associated with this gene (DisGeNET).

Gene ID

Gene Symbol

Disease ID

Disease Name

Number of PMID

Source

	Gene summary
	Gene structure and Gene expression level
	Sex-biased somatic mutation
	DNA methylation with beta values in gene
	Exon skipping events with PSI in TCGA
	RNA A-to-I editing events in TCGA
	Sex-biased TF-Gene network of gene
	Sex-biased RBP-ES network of gene
	Sex-biased CeRNA regulation of gene
	Sex-biased eQTL regulation of gene
	Sex-biased eQTM regulation of gene
	Sex-biased sQTL regulation of gene
	Sex-biased sQTM regulation of gene
	Related disease information of gene